Finnrick - Ensuring a Safer and More Transparent Supply Chain
Haikou Mingheng Biotechnology

Haikou Mingheng Biotechnology

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Haikou Mingheng Biotechnology between 18 Sep 2025 and 10 Mar 2026. Test scores average over 4, no score below 3, and at least 6 tests warrant a confident Finnrick Rating of D (Poor).

Finnrick Rating™
Haikou Mingheng Biotechnology
Retatrutide
Tested 6 Samples
Last test 10 Mar 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Haikou Mingheng Biotechnology

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.0MIN3.8MAX8.0

Last

10 Mar 2026

First

18 Sep 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
10 Mar 2026View4.720mg10.9mg-45.5%99.90%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
26 Feb 2026View5.015mg15mg96.68%(no batch ID)White Label / Silver Crimp / Black CapLab EPublic
7 Jan 2026View7.315mg15.3mg+2.0%99.60%(no batch ID)White Label / Copper Crimp / Clear Cap Lab GPublic
18 Nov 2025View3.85mg5.65mg+13.0%98.90%(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic
6 Nov 2025View7.210mg9.59mg-4.1%99.56%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
18 Sep 2025View8.030mg28.9mg-3.7%99.95%(no batch ID)No Label / Silver Crimp / Pink Cap Lab EPublic